SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-002717
Filing Date
2024-08-21
Accepted
2024-08-21 07:00:21
Documents
31
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K zk2431846.htm   iXBRL 6-K 21114
2 EXHIBIT 99.1 exhibit_99-1.htm   iXBRL EX-99.1 469707
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 156949
4 EXHIBIT 99.3 exhibit_99-3.htm EX-99.3 159351
  Complete submission text file 0001178913-24-002717.txt   2147690

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cmmb-20240630.xsd EX-101.SCH 21302
6 XBRL CALCULATION FILE cmmb-20240630_cal.xml EX-101.CAL 24395
7 XBRL DEFINITION FILE cmmb-20240630_def.xml EX-101.DEF 45459
8 XBRL LABEL FILE cmmb-20240630_lab.xml EX-101.LAB 219601
9 XBRL PRESENTATION FILE cmmb-20240630_pre.xml EX-101.PRE 89756
33 EXTRACTED XBRL INSTANCE DOCUMENT zk2431846_htm.xml XML 99660
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 241227186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)